Skip to main content
Clinical Trials/NCT04759872
NCT04759872
Terminated
Not Applicable

Insulin and Muscle Fat Metabolism

Oregon State University1 site in 1 country9 target enrollmentFebruary 22, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overweight and Obesity
Sponsor
Oregon State University
Enrollment
9
Locations
1
Primary Endpoint
Changes in skeletal muscle lipid content during hyperinsulinemia compared with basal resting conditions
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

Our objective in this study is to identify the extent to which insulin drives the accumulation of lipids in skeletal muscle of humans. We will test the hypothesis that 4-hours of mild hyperinsulinemia will result in significant muscle lipid accumulation and that such effects will be similar in lean and overweight/obese humans.

Registry
clinicaltrials.gov
Start Date
February 22, 2021
End Date
June 7, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sean Newsom

Associate Professor

Oregon State University

Eligibility Criteria

Inclusion Criteria

  • Age 30-55 years
  • Body mass index (BMI) 18-45 kg/m2
  • Sedentary (\<1 hour of planned exercise per week)

Exclusion Criteria

  • Regular exercise (\>1 hour of planned exercise per week)
  • Smoking, tobacco or nicotine use within the last 1-year
  • Fasting glucose \>126mg/dL
  • Hypertension (systolic pressure \>140 mmHg or diastolic pressure \>90 mmHg)
  • Chronic metabolic or cardiovascular health conditions
  • Pregnant, nursing, irregular menses or post-menopausal
  • Lidocaine allergy
  • Certain medications
  • Diminished capacity for consent

Outcomes

Primary Outcomes

Changes in skeletal muscle lipid content during hyperinsulinemia compared with basal resting conditions

Time Frame: Muscle samples will be collected in basal and hyperinsulinemic conditions separated by ~4.5 hours during the metabolic study visit

Liquid chromatography tandem mass spectrometry (targeted lipidomics) will be used to assess species-level changes in skeletal muscle lipid content in biopsy samples collected before and after the insulin infusion to induce mild hyperinsulinemia.

Secondary Outcomes

  • Changes in skeletal muscle mitochondrial oxidative capacity during hyperinsulinemia compared with basal resting conditions(Muscle samples will be collected in basal and hyperinsulinemic conditions separated by ~4.5 hours during the metabolic study visit)

Study Sites (1)

Loading locations...

Similar Trials